SavedAdd your journal

Journals / Astım Allerji İmmünoloji / 2021 / Cilt: 19 - Sayı: 1

Retrospective Analysis of Autoimmune Diseases and Immunologic Characteristics of the Adult Primary Immune Deficiency Cohort: 17 Years Experience of the Tertiary Referral Immunology Center in Turkey

Ceyda TUNAKAN DALGIÇ
Aytül Zerrin SİN
Fatma Ömür ARDENİZ
Pages
12–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients presenting with multiple ADsshould be screened for having an underlying PID.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Primary immunodeficiencies (PIDs) consist of genetically heterogeneous disorders.
📊
Key Findings & Data:We aimed to analyze the frequency and variety of autoimmune diseases (ADs) in PIDsand describe their clinical and laboratory features.Materials and Methods: Ninety-two patients with PID followed by Ege University Medical Faculty between 2000 and 2017 wereenrolled in this retrospective, cross-sectional study.
💡
Conclusion & Impact:Patients presenting with multiple ADsshould be screened for having an underlying PID.
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Primary immunodeficiencies (PIDs) consist of genetically heterogeneous disorders. The spectrum can include infectiousdiseases, malignancy, allergy, and autoimmunity. We aimed to analyze the frequency and variety of autoimmune diseases (ADs) in PIDsand describe their clinical and laboratory features.Materials and Methods: Ninety-two patients with PID followed by Ege University Medical Faculty between 2000 and 2017 wereenrolled in this retrospective, cross-sectional study. All patients’ medical records were reviewed using the demographic information,type of PIDs and ADs, ADs-related autoantibodies, and basic and immunologic laboratory findings. ADs were diagnosed using clinicaland complementary paraclinical findings by an immunologist and/or a subspecialist related to the affected organ or system.Results: We evaluated 50 male and 42 female PID patients with a mean age of 40.92 (18-86). Twenty-nine (32 %) patients (15 females/14males) with a mean age of 43.8 (19-78) had ADs. In our study group, the most commonly detected type of PID with AD is commonvariable immune deficiency (CVID) (n=17); followed by combined immune deficiency (CID) (n=3), CTLA4 deficiency (n=2),selective IgA deficiency (sIgAD) (n=2), specific IgG subgroup deficiency (n=1), autoimmune polyglandular syndrome (APS) withhypogammaglobulinemia (n=1), dyskeratosis congenita (DC) (n=1), Osler-Rendu-Weber (ORW) syndrome with CVID-like PID (n=1),and cartilage-hair hypoplasia (CHH) (n=1). According to systematic assessments, ADs resulted in endocrinologic 14%, dermatologic10.8%, rheumatologic 9.7%, gastroenterological 9.7%, hematological 8.6%, and neurologic disorders 1%. The frequency of ADs washigher in CVID cases than other types of PIDs (p <0.05). Basic and immunologic laboratory findings of the PIDs with and without ADswere analyzed and compared; however, no statical significant difference was obtained between the groups.Conclusion: We have analyzed the frequency and variety of ADs in a adult PID cohort in Turkey. Patients presenting with multiple ADsshould be screened for having an underlying PID.

🔖

Cite This Article

DALGIÇ, C. T., SİN, A. Z., ARDENİZ, F. Ö. (2021). Retrospective Analysis of Autoimmune Diseases and Immunologic Characteristics of the Adult Primary Immune Deficiency Cohort: 17 Years Experience of the Tertiary Referral Immunology Center in Turkey. Astım Allerji İmmünoloji, Cilt: 19 - Sayı: 1, 12–23. https://ajindex.com/articles/351217

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Schmidt RE, Grimbacher B, Witte T. Autoimmunity and primary immunodeficiency: Two sides of the same coin? Nat Rev Rheumatol 2017;14(1):7-18
  2. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol 2018;38(1):96- 128
  3. Lugo Reyes SO, Ramirez-Vazquez G, Cruz Hernández A, Medina-Torres EA, Ramirez-Lopez AB, España-Cabrera C, et al. Clinical features, non-infectious manifestations and survival analysis of 161 children with primary immunodeficiency in Mexico: A single center experience over two decades. J Clin Immunol 2016;36(1):56-65
  4. Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: Update and new insights from the third report of the national registry. J Clin Immunol 2014;34(4):478-90
  5. Yazdani R, Latif A, Tabassomi F, Abolhassani H, Azizi G, Rezaei N, et al. Clinical phenotype classification for selective immunoglobulin A deficiency. Expert Rev Clin Immunol 2015;11(11):1245-54
  6. Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, et al. Autoimmunity in common variable immunodeficiency: Epidemiology, pathophysiology and management. Expert Rev Clin Immunol 2017;13(2):101-15
  7. Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun Rev 2006;5: 465-70
  8. Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 2006;5:156-9
  9. Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev 2009;8(4):332-6
  10. Haymore BR, Mikita CP, Tsokos GC. Common variable immune deficiency (CVID) presenting as an autoimmune disease: The role of memory B cells. Autoimmun Rev 2008; 7: 309-12
  11. Azizi G, Ziaee V, Tavakol M, Alinia T, Yazdai R, Mohammadi H, et al. Approach to the management of autoimmunity in primary immunodeficiency. Scand J Immunol 2017;85(1):13-29
  12. Arason GJ, Jorgensen GH, Ludviksson BR. Primary immunodeficiency and autoimmunity: Lessons from human diseases. Scand J Immunol 2010;71(5):317-28
  13. Atkinson TP. Immune deficiency and autoimmunity. Curr Opin Rheumatol 2012;24(5):515-21
  14. Sharfe N, Merico D, Karanxha A, Macdonald C, Dadi H, Ngan B, et al. The effects of RelB deficiency on lymphocyte development and function. J Aut